Expression of antigen processing and presenting molecules in brain metastasis of breast cancer

Yan Liu, Yoshihiro Komohara, Natalie Domenick, Masasuke Ohno, Maki Ikeura, Ronald L. Hamilton, Craig Horbinski, Xinhui Wang, Soldano Ferrone, Hideho Okada*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

45 Scopus citations


Defects in human leukocyte antigen class I antigen processing machinery (APM) component expression can have a negative impact on the clinical course of tumors and the response to T cell-based immunotherapy. Since brain metastases of breast cancer are of increasing clinical significance, the APM component expression levels and CD8 + T cell infiltration patterns were analyzed in primary breast and metastatic brain lesions of breast cancer by immunohistochemistry. Comparison of unpaired 50 primary and 33 brain metastases showed lower expression of β2-microglobulin, transporter associated with antigen processing (TAP) 1, TAP2 and calnexin in the brain lesions. Although no significant differences were found in APM component scores between primary breast and brain lesions in 15 paired cases, primary breast lesions of which patients eventually developed brain metastases showed lower levels of β2-microglobulin, TAP1 and calnexin compared with breast lesions without known brain metastases. The extent of CD8 + T cell infiltration was significantly higher in the lesions without metastasis compared with the ones with brain metastases, and was positively associated with the expression of TAP1 and calnexin. Furthermore, mouse tumor cells stably transfected with silencing hairpin (sh)RNA for TAP1 demonstrated a decreased susceptibility to cytotoxic T lymphocytes in vitro and enhanced spontaneous brain metastasis in vivo. These data support the functional significance of TAP1 expression in tumor cells. Taken together, our data suggest that patients with low or defective TAP1 or calnexin in primary breast cancers may be at higher risks for developing brain metastasis due to the defects in T cell-based immunosurveillance.

Original languageEnglish (US)
Pages (from-to)789-801
Number of pages13
JournalCancer Immunology, Immunotherapy
Issue number6
StatePublished - Jun 2012


  • Antigen processing machinery (APM) components
  • Brain metastasis
  • Breast cancer
  • CD8 T cell
  • Transporter associated with antigen processing (TAP)1

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Oncology
  • Cancer Research


Dive into the research topics of 'Expression of antigen processing and presenting molecules in brain metastasis of breast cancer'. Together they form a unique fingerprint.

Cite this